Argitalpenak (76) ANTONIO SORLOZANO PUERTO argitalpenak

2022

  1. Características sociodemográficas y factores de riesgo asociados a las bacteriurias significativas en un área de salud del sudeste español

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 382-391

  2. Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia

    Genes, Vol. 13, Núm. 6

2021

  1. Antibacterial and antifungal activity of propyl-propane-thiosulfinate and propyl-propane-thiosulfonate, two organosulfur compounds from allium cepa: In vitro antimicrobial effect via the gas phase

    Pharmaceuticals, Vol. 14, Núm. 1, pp. 1-17

  2. Antimicrobial activity of the circular bacteriocin as-48 against clinical multidrug-resistant staphylococcus aureus

    Antibiotics, Vol. 10, Núm. 8

  3. Etiología de las infecciones urinarias en nuestra área sanitaria y perfil de sensibilidad de los uropatógenos más frecuentes

    Archivos espanoles de urologia, Vol. 74, Núm. 2, pp. 197-207

2020

  1. Characterization of fosfomycin and nitrofurantoin resistance mechanisms in escherichia coli isolated in clinical urine samples

    Antibiotics, Vol. 9, Núm. 9, pp. 1-19

  2. Effectiveness of electronic guidelines (GERH®) to improve the clinical use of antibiotics in an intensive care unit

    Antibiotics, Vol. 9, Núm. 8, pp. 1-22

2019

  1. Evolution of the antibiotic-resistance of microorganisms causing urinary tract infections: A 4-year epidemiological surveillance study in a hospital population

    Revista Clinica Espanola, Vol. 219, Núm. 3, pp. 116-123

2018

  1. Estudio prospectivo de la incidencia de patógenos genitales oportunistas y estrictos que crecen en medios de cultivo artificiales

    Revista del laboratorio clínico, Vol. 11, Núm. 3, pp. 123-130

  2. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from urinary tract infections: Evolution of antimicrobial resistance and treatment options

    Medicina Clinica, Vol. 150, Núm. 7, pp. 262-265

  3. In vitro antibacterial activity of propyl-propane-thiosulfinate and propyl-propane-thiosulfonate derived from allium spp. Against gram-negative and gram-positive multidrug-resistant bacteria isolated from human samples

    BioMed Research International, Vol. 2018

  4. Inpatient candiduria: Etiology, susceptibility to antifungal drugs and risk factors

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 4, pp. 323-328

  5. Prospective study of the incidence of opportunistic and strict genital pathogens that grow in artificial culture media

    Revista del Laboratorio Clinico, Vol. 11, Núm. 3, pp. 123-130

  6. Susceptibility of clinical isolates of Campylobacter jejuni and Campylobacter coli to colistin

    New Microbiologica, Vol. 41, Núm. 3, pp. 235-237

2017

  1. Activity of fosfomycin on clinical isolates of Campylobacter jejuni and Campylobacter coli of enteric origin

    Antimicrobial Agents and Chemotherapy

  2. Assessment of adherence to antibiotic treatment in Primary Care by determining levels of the drug using a liquid chromatography technique

    Revista Espanola de Quimioterapia, Vol. 30, Núm. 5, pp. 341-349

  3. Etiological and Resistance Profile of Bacteria Involved in Urinary Tract Infections in Young Children

    BioMed Research International, Vol. 2017

  4. Prevalence and genetic diversity of Trichomonas vaginalis in the general population of Granada and co-infections with Gardnerella vaginalis and Candida species

    Journal of Medical Microbiology, Vol. 66, Núm. 10, pp. 1436-1442

2016

  1. A new case report of urinary tract infection due to KPC-3-producing Klebsiella pneumoniae (ST258) in Spain

    Archivos Espanoles de Urologia, Vol. 69, Núm. 7, pp. 437-440

  2. Development of a web application for recording bacterial etiologic agents and their antimicrobial susceptibility to improve the treatment of urinary tract infections and monitor resistance to antibiotics

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 29, Núm. 2, pp. 99-104